Mechanistically, radiochemotherapy upregulates the expression of vascular endothelial growth factor receptor 2 (VEGFR2) in glioma [37], therefore increases tumor's dependence on VEGF pathway activation and sensitivity to BEV [38, 39]. This evidence concerns the gene KDR and neoplasm.